| ²é¿´: 565 | »Ø¸´: 0 | ||
Ñî´ó´óµÄfeelгæ (СÓÐÃûÆø)
|
[ÇóÖú]
¼ÆËã»ú¸¨ÖúÒ©ÎïÉè¼ÆÖйØÓÚ·Ö×Ó¶Ô½ÓÎÊÌâÇóÖú
|
|
compound 1 presented in different protonated form. If same protocol/method followed for ligand preparation, why the same compound represented differently? This can affect dock score significantly. Clarify. ÂÛÎÄÖÐÒ»¸ö»¯ºÏÎï¶Ô½Óµ½Á½¸ö²»Í¬µÄ°ÐµãʱÖÊ×Ó»¯ÐÎʽ²»Í¬£¬ÔõÑù»Ø¸´ÒÔÉÏÎÊÌâ |
» ²ÂÄãϲ»¶
£Ûµ÷¼ÁÐÅÏ¢£Ý211ÖÇÄÜÈ˹¤¸ÐÖª·½Ïò¹ú¼ÒÇàÄêÌØÆ¸×¨¼Ò¿ÎÌâ×éÕÐÊÕµ÷¼ÁÑо¿Éú
ÒѾÓÐ0È˻ظ´
[µ÷¼ÁÐÅÏ¢]211ÖÇÄÜÈ˹¤¸ÐÖª·½Ïò¹ú¼ÒÇàÄêÌØÆ¸×¨¼Ò¿ÎÌâ×éÕÐÊÕµ÷¼ÁÑо¿Éú
ÒѾÓÐ0È˻ظ´
ÎïÀíѧIÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ128È˻ظ´
0702Ò»Ö¾Ô¸¼ª´óBÇøÇóµ÷¼Á ±¾¿ÆÆÚ¼ä·¢±íһƪSci
ÒѾÓÐ2È˻ظ´
070200Çóµ÷¼Á£¬Ò»Ö¾Ô¸Ä³211£¬288·Ö
ÒѾÓÐ18È˻ظ´
·¨¹ú²©Ê¿ºóְλ
ÒѾÓÐ0È˻ظ´
ÖØÇì½»´ó26Äê˶ʿÉúÕÐÉúÄâµ÷¼Á֪ͨÒѳö£¡»¶Ó¼ÓÈë»úÆ÷ÊÓ¾õÓë3D¹âѧ³ÉÏñ¿ÎÌâ×é¡£
ÒѾÓÐ0È˻ظ´
¹ãÖÝ´óѧ¹âµçÐÅÏ¢¹¤³Ìרҵµ÷¼Á£¬ÕÐÊÕÎïÀíѧרҵѧÉú
ÒѾÓÐ1È˻ظ´
0702Ò»Ö¾Ô¸¼ª´óBÇøÇóµ÷¼Á ±¾¿ÆÆÚ¼ä·¢±íһƪSci
ÒѾÓÐ0È˻ظ´














»Ø¸´´ËÂ¥